The <i>Aspergillus</i> Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update.

Loading...
Thumbnail Image

Date

2020-01

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

6
views
17
downloads

Citation Stats

Abstract

Purpose of review

To review the data on the Aspergillus lateral flow assay for the diagnosis of invasive Aspergillosis.

Recent findings

Aspergillus spp. cause a wide spectrum of disease with invasive aspergillosis (IA) as its most severe manifestation. Early and reliable diagnosis of disease is crucial to decrease associated morbidity and mortality, and enable prompt initiation of treatment for IA. Most recently, non-culture-based tests, such as Aspergillus galactomannan (GM), have been useful in early identification and treatment of patients with IA. However, cost, turnaround time, and variable performance indifferent populations at risk for IA remain significant drawbacks to the use of this test. Several diagnostic tests for IA have been developed, including the sōna Aspergillus GM Lateral flow assay (GM-LFA) rapid test.

Summary

The GM-LFA has shown excellent performance for the diagnosis of IA in patients with hematologic malignancy and may be a viable option for settings where ELISA GM testing is not feasible. Further evaluation of the GM-LFA in the non-hematology setting is ongoing, including in solid organ transplant recipients and patients in the intensive care unit.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1007/s12281-020-00409-z

Publication Info

Jenks, Jeffrey D, Marisa H Miceli, Juergen Prattes, Toine Mercier and Martin Hoenigl (2020). The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update. Current fungal infection reports, 14(4). pp. 378–383. 10.1007/s12281-020-00409-z Retrieved from https://hdl.handle.net/10161/28610.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Jenks

Jeffrey Daniel Jenks

Adjunct Associate Professor in the Department of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.